First Financial Bankshares’s Neurocrine Biosciences NBIX Stock Holding History

First Financial Bankshares’s Portfolio NBIX Stock Details NBIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.07M	Buy	38,497 +644	+2%	+$85.4K	0.1%	79
2025 Q4	$5.37M	Buy	37,853 +9,427	+33%	+$1.37M	0.11%	75
2025 Q3	$3.99M	Sell	28,426 -152	-0.5%	-$20.6K	0.08%	83
2025 Q2	$3.59M	Buy	28,578 +807	+3%	+$92.5K	0.08%	83
2025 Q1	$3.07M	Buy	27,771 +829	+3%	+$105K	0.07%	81
2024 Q4	$3.68M	Buy	26,942 +9,208	+52%	+$1.14M	0.08%	81
2024 Q3	$2.04M	Buy	17,734 +1,058	+6%	+$145K	0.04%	93
2024 Q2	$2.3M	Buy	16,676 +483	+3%	+$66.2K	0.05%	87
2024 Q1	$2.23M	Buy	16,193 +391	+2%	+$53.4K	0.05%	91
2023 Q4	$2.08M	Buy	+15,802	New	+$1.82M	0.05%	93

Other funds holding NBIX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Financial Bankshares's NBIX Position: Q1 2026 in Review

First Financial Bankshares increased its Neurocrine Biosciences (NBIX) stake by 1.7% in Q1 2026, buying an estimated $85.4K and bringing the position to 38,497 shares worth $5.07M. The position accounts for 0.1% of the portfolio, ranked #79.

First Financial Bankshares first reported a position in NBIX in Q4 2023 and has held it in 10 quarters since. The position peaked at $5.37M in Q4 2025. 694 funds tracked by Wall St. Rank hold NBIX as of Q1 2026.

First Financial Bankshares held 38,497 shares of Neurocrine Biosciences worth $5.07M as of Q1 2026.
First Financial Bankshares bought 644 Neurocrine Biosciences shares in Q1 2026, an estimated $85.4K.
Neurocrine Biosciences made up 0.1% of First Financial Bankshares's portfolio in Q1 2026, its #79 holding.
First Financial Bankshares first reported a position in Neurocrine Biosciences in Q4 2023 and has held it in 10 quarters since.
First Financial Bankshares's Neurocrine Biosciences position peaked at $5.37M in Q4 2025.
694 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q1 2026.

Based on First Financial Bankshares's 13F filing for Q1 2026, filed 11 May 2026.